~~<i id='171D1E98A4'><strike id='171D1E98A4'><tt id='171D1E98A4'><pre id='171D1E98A4'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

fashion

author：fashion 2025-10-01 17:35:29 - browse：6

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

A couple billion here, a couple billion there, and pretty soon Eli Lilly hopes it will be talking about real money.

Eli Lilly agreed to purchase Point Biopharma Tuesday morning for $1.4 billion, a 90% premium, adding to its pipeline of cancer drugs. Point is developing cancer drugs that deliver a focused dose of radiation to tumor cells. Data for its lead medicine, for prostate cancer, are expected in the fourth quarter. It is also developing a drug for neuroendocrine tumors.

Point operates a 180,000-square-foot radiopharmaceutical manufacturing facility in Indianapolis, and a radiopharmaceutical research and development center in Toronto.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Medicare isn't yet testing food as medicine

explore

Wikipedia

entertainment

hotspot

knowledge

entertainment

FarmworkerspickinggrapesinCalifornia'sCentralValleyduringthe2021heatwave.FREDERICJ.BROWN/AFPviaGetty

WSS

Medicare Advantage isn’t working — for anyone

5 ways to address the shortage of health care workers

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

Medicare says breakthrough device reimbursement rule to come by summer

H5N1 communication has been strictly for the birds

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

entertainment

fashion

explore

Jerome Adams on the need for new antivirals for Covid

Readout LOUD podcast: brain research, obesity drug sales, Novartis

Activists slam private health insurers over coverage restrictions

Children’s Hospital revives plan for pedestrian bridge

Cancer drug shortages should be causing more outrage

Laying a path for careers in science

Medical records are filled with copy

Study fuels hope CAR

Malaria cases in Florida and Texas: Here’s what you need to know

Are embryos people? Reproductive medicine's future depends on the answer

Wikipedia

Virtual repurposing can help discover new uses for existing drugs

Study: People of West African ancestry at greater risk of cardiac amyloidosis

Shionogi licenses Pompe disease therapy from Maze Therapeutics

Brain worms: The science behind RFK Jr.'s parasitic infection

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

Color Health wants to make cancer screenings convenient

entertainment

hotspot

knowledge

entertainment